Plain-English translation of NCT07643896 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying a new blood test called UNITY Confirm that looks for fetal cells—tiny cells from the placenta—in the mother's blood to check for genetic conditions like Down syndrome and other chromosomal abnormalities. Unlike older screening tests that analyze fragmented DNA, this test isolates complete fetal cells and analyzes them directly. The study will enroll over 1,000 pregnant people to see how well this new approach works.
Current screening tests for genetic conditions in pregnancy have limitations and sometimes require follow-up invasive procedures. This study aims to develop a better, non-invasive way to screen for chromosomal abnormalities early in pregnancy by directly analyzing fetal genetic material from the mother's blood.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll have a blood sample drawn, which is then analyzed using the new UNITY Confirm test. Your results will be compared with other prenatal or postnatal diagnostic information to help researchers understand how accurate the test is. The study will follow you through your pregnancy to collect outcomes.
AI-generated summary from trial data · Aug 27, 2026 · Not medical advice
United States